Incidence of IGF1R(+)/E‐cadherin(+) and IGF1R(−)/E‐cadherin(−) CTC phenotypes among patients and among the total CTCs detected in early and metastatic breast cancer (triple immunofluorescence analysis). This evidence concerns the gene CDH1 and breast carcinoma.